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The Flemish Environment and Health Study
(FLEHS) evaluated whether residence in areas
with different types and concentrations of
environmental pollutants had a significant
impact on internal exposure to pollutants and
whether place of residence or observed differ-
ences in internal pollutant concentrations
were associated with biologic and health
effects. We measured both internal exposure
and effect biomarkers on an individual basis,
in residents of Wilrijk and Hoboken, indus-
trial suburbs of the city of Antwerp, Belgium,
and of Peer, a rural municipality in Flanders,
the Dutch-speaking northern part of Belgium.
Characteristics of the study areas have been
described previously (van Larebeke et al.
2004). Results concerning adolescents from
the same areas have been published (Nawrot
et al. 2002; Staessen et al. 2001; Van Den
Heuvel et al. 2002).
During the long latency period after
initiation of carcinogenesis and/or under the
impact of tumor promoters, some cells in the
body might express certain aspects of the
tumoral phenotype, which may result in
macromolecules associated with this pheno-
type being released into body fluids. An
increased concentration of such molecules in
body fluids might, to some extent, reflect a
higher exposure to cancer-inducing or cancer-
promoting agents (Koshida et al. 1990;
Krajewska et al. 1998; Luo et al. 1999; Lutz
et al. 1997; Wong et al. 2002) or an increased
risk of cancer (Brandt-Rauf and Pincus 1998;
Giovannuci 1999; Hankinson et al. 1998;
Jacobs et al. 1996; Jeyarajah et al. 1999;
Kobayashi and Kawakubo 1994; Oka et al.
1994; Wolk et al. 1998). At the beginning of
our study, we hypothesized that differences in
exposure to pollutants between the three study
areas might have led, directly or through
diverse cancer-related biologic processes, to
differences in tumor-associated protein (TAP)
levels. In this article we report on TAP levels
in serum or urine of 200 nonsmoking women
50–65 years of age (100 from Peer, 39 from
Wilrijk, and 61 from Hoboken). Possible
confounders related to lifestyle and personal
characteristics were taken into account.
Results concerning dioxins and poly-
chlorinated biphenyls (PCBs) on adults in the
FLEHS have already been published (Covaci
et al. 2001; Koppen et al. 2001). We previ-
ously (van Larebeke et al. 2004) reported data
on hypoxanthine phosphoribosyltransferase
(HPRT) gene mutant frequency (HPRTmf) in
a subset of the subjects participating in the
present study.
Materials and Methods
Selection of study areas. Hoboken and Wilrijk
are located 11–13 km southeast of the chemi-
cal and petrochemical industry established in
the seaport of Antwerp. Hoboken harbors a
large nonferrous smelter (the cause of impor-
tant lead pollution in the past), other metal-
lurgic industries, a large printer, and plants
producing electronic equipment. The mean
lead concentration of suspended particles dur-
ing 1997 in Hoboken was between 0.08 and
1.35 µg/m3, depending on the location. Wilrijk
contains metallurgic industry, plastic industry,
a printer, a crematorium, and two waste incin-
erators with annual turnovers of 23,000 and
110,000 tons; these incinerators were shut
down in November 1997 because of dioxin
emissions exceeding the acceptable level [0.1 ng
2,3,7,8-tetrachlorodibenzodioxin (TCDD)
toxic equivalents (TEQ)/m3] by 20-fold. Both
Hoboken and Wilrijk are traversed by a high-
way traveled by > 80,000 vehicles a day. Peer
(14,622 inhabitants), an area of intensive agri-
culture, is situated in a rural area 70 km east of
Antwerp. Although there is a military airﬁeld
about 5 km north of the municipality and
some polluting industries about 15 km away,
measured environmental pollution was lower in
Peer than in many other places in Flanders.
Sources of and data on environmental pollu-
tion of these municipalities were described
previously (van Larebeke et al. 2004).
Selection of the study population. We
chose middle-age women because they spent
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We measured tumor-associated proteins (TAPs) and pollutants in blood, serum, and urine of
200 nonsmoking women 50–65 years of age, residing in the rural municipality of Peer or in
Hoboken or Wilrijk, industrial suburbs of Antwerp, Belgium. Persons with occupational expo-
sures or commuting to other towns were excluded. Residents from Hoboken had significantly
higher levels of blood lead and serum zinc and polychlorinated biphenyls. Surprisingly, residents of
Peer had signiﬁcantly higher levels of serum cadmium, dioxin-like activity in blood fat, and urinary
1-hydroxypyrene. For 5 of the 12 TAPs assessed in this study, we observed signiﬁcant differences in
serum levels among residents of the three municipalities after adjusting for personal or lifestyle
parameters. Although we found levels of internal exposure to pollutants to be quite homogeneous
in Flanders, we found signiﬁcantly higher levels of TAPs only in the industrial suburbs. In multiple
regression with all 29 available personal, lifestyle, and internal exposure parameters, blood lead
levels showed a positive association with serum levels of anti-p53, carcino-embryonic antigen
(CEA), and tissue polypeptide–speciﬁc antigen (TPS) and with an index for mean TAP level (Itap);
dioxin-like activity in serum and serum copper showed a positive association with serum CA 125
(cancer antigen 125); and serum zinc showed a positive association with serum levels of c-erbB-2
ectodomain and TPS. An index of internal exposure showed a positive association with serum levels
of both CEA and anti-p53 and with Itap. This study provides some evidence that levels of internal
exposure such as those present in Flanders, in particular concerning lead, are indeed associated with
biologic effects. Key words: anti-p53, biomonitoring, bladder tumor antigen, CA 125, cancer,
dioxin-like activity, environment, lead, tumor markers, zinc. Environ Health Perspect 114:887–892
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and working at home. We measured TAP lev-
els in serum samples from 200 women from
Hoboken (n = 61), Wilrijk (n = 39), and Peer
(n = 100) recruited between June and
September 1999. To obtain the planned
200 women for the study, we used the follow-
ing selection strategy. We contacted (only one
attempt) all female residents 50–65 years of age
(2,898 women) by letter containing a ques-
tionnaire on age, duration of residence, smok-
ing, occupation and place of occupation,
number of children, consumption of vegetables
or fruit from the family’s garden, and vege-
tarianism. In Hoboken/Wilrijk and Peer,
40.1% and 30.8% responded, respectively. We
used the following two inclusion criteria: mini-
mal residence of 10 years in the study area and
employment in the town of residence or at
home for at least 10 years. We excluded smok-
ers and persons who stopped smoking
< 10 years before the start of the study as well
as persons who were ever employed in jobs
with specific risks of exposure. Having been
diagnosed with cancer or another disease was
not an exclusion criterion. We ranked the
remaining 685 women by duration of residence
and smoking history, with never-smokers
given priority and ex-smokers prioritized by
time elapsed since cessation of smoking. In
order to reach 100 participants per region, we
used telephone calls to invite 130 women
from Wilrijk or Hoboken and 125 women
from Peer to participate in the study. Of the
130 residents from Wilrijk or Hoboken,
12 refused to participate and 18 others did not
participate for other reasons. Of the 125 resi-
dents from Peer, 14 refused to participate and
11 others did not participate for other reasons.
We noted no signiﬁcant differences between
participants and nonparticipants in terms of
their responses to items in the questionnaire.
All participants gave their written informed
consent. Throughout the study, a communica-
tion plan (with the participants and local
authorities) was in force. Each participant was
offered the possibility of having an interview
with a physician-researcher. We complied with
all applicable requirements. The study was
approved by the institutional review board of
the University of Antwerp.
Measured parameters. We measured height
and body weight, calculated body mass index
(BMI), and collected approximately 200 mL
urine and 40 mL blood from each subject.
Blood samples were collected in polyethylene
tubes. Immediately after sampling, serum was
separated. Split samples of serum, plasma,
whole blood, and urine were stored at 4°C or
immediately deep frozen. All laboratory analy-
ses were performed blindly in specialized labo-
ratories that met national and international
quality-control standards. For each participant,
we performed a series of routine hematologic
tests and determined serum concentrations of
total fat, triglycerides, cholesterol, selenium,
vitamin A, vitamin E, zinc, and copper. We
measured the following biomarkers of exposure
in serum, blood, or urine as described previ-
ously (van Larebeke et al. 2004): dioxin-like
activity, expressed in picograms TEQ per gram
blood fat; PCB-138, PCB-153, and PCB-180
(indicator PCBs), expressed in nanograms per
gram blood fat [we calculated the sum of the
concentrations of these PCBs (Σ3PCBs) to use
as a parameter in statistical analysis]; cadmium
in urine and blood; lead in blood; and
1-hydroxypyrene in urine. TAP levels in urine
[bladder tumor antigen (BTA)] or serum (all
other parameters) were measured by Interlab
(Evergem, Belgium), a laboratory recognized
by the Belgian Ministry of Health as a refer-
ence laboratory for tumor markers. We meas-
ured the following TAPs: tissue polypeptide–
speciﬁc antigen (TPS; TPS IRMA kit; BEKI
Diagnostics, Bromma, Sweden); human pla-
cental alkaline phosphatase (hPLAP; Innotest
hPLAP kit; Innogenetics, Ghent, Belgium);
c-erbB-2 ectodomain (c-erbB-2; Human neu
Quantitative ELISA kit; Oncogene Research
Products, Cambridge, MA, USA); insulin-
like growth factor-I (IGF-I; IGF-I ELISA,
DSL-10-600 kit; DSL, Webster, TX, USA);
platelet-derived growth factor BB (PDGF-BB;
Quantikine Human PDGF-BB kit; R&D
Systems, Minneapolis, MN, USA); carcino-
embryonic antigen (CEA; IRMA-coat CEA
kit; Byk-Sangtec Diagnostica, Dietzenbach,
Germany); cancer antigen (CA) 15-3 (IRMA-
count BR-MA kit; DPC, Los Angeles CA,
USA); CA 125 (IRMA-mat CA 125 II kit;
DPC);  α-fetoprotein (AFP; COAT-A-
COUNT AFP IRMA kit; DPC); BTA (BTA
TRAK kit; Bard Diagnostic Sciences,
Redmond, WA, USA); anti-p53 (Anti-p53
ELISA kit; PharmaCell, Paris, France); soluble
interleukin-2 receptor (sIL-2R; Milenia IL2R
kit; DPC). Except for BTA, urinary measure-
ments were standardized to 1 mmol creati-
nine. Coefﬁcients of variation of the TAPs in
the clinically normal range in our laboratory
(expressed as percentage) were 5.0% for
anti-p53, 5.0% for c-erbB-2, 8.7% for TPS,
7.1% for AFP, 9.8% for CEA, 6.5% for
CA 15-3, 11.0% for CA 125, not available for
hPLAP, 4.7% for BTA, 7.1% for IGF-I, 8.5%
for sIL-2R, and 7.7% for PDGF-BB.
Parameters resulting from questionnaires.
All participants filled out a self-reporting
questionnaire on education, residence history,
food intake, smoking, alcohol habits, and
health status. We classified education by the
highest education received: primary school or
the ﬁrst 3 years of secondary school, complete
secondary school, and higher education. We
considered participants ex-smokers if they had
smoked at least one cigarette per day for at
least 1 year; participants who smoked less
than this were classiﬁed as never-smokers. We
used the following food-intake parameters,
calculated from the questionnaires on dietary
habits over the last year: ethanol in grams per
day, total daily intake of animal fat in grams,
frequency of consumption of dairy products
per day, total daily intake of calcium in milli-
grams, and number of different types of
locally grown food items regularly consumed.
Also, we recorded frequencies of monthly
consumption of meat (smoked, salted, grilled,
roasted, baked, or organ meat); baked,
roasted, or grilled meat; ﬁsh; smoked or salted
meat or ﬁsh; ﬁsh, ﬁsh organ meat, mussels or
shrimp; and vegetables from own garden. In
addition, we calculated the total number of
pregnancies and the total number of weeks of
breast-feeding. We made no attempt to col-
lect information on occurrence of cancer in
family members.
Statistical analyses. For each TAP and for
each biomarker of exposure we calculated a
standard or z-score for each individual by
dividing the difference between the value for
that individual and the mean value for the
entire subject population by the standard
deviation for the entire subject population.
We calculated for each individual an index of
mean TAP level (Itap), defined as the arith-
metic mean of the z-scores for each type of
TAP [Itap = (zTPS + zhPLAP + zc-erbB-2 + zIGF-I +
zPDGF-BB + zCEA + zCA 15-3 + zCA 125 + zAFP +
zBTA + zanti-p53 + zsIL-2R)/12]. For each subject
we calculated an index of internal exposure
(Iex), defined as the arithmetic mean of the
z-scores for blood lead concentration;
Σ3PCBs; dioxin-like activity in serum meas-
ured by the chemically activated luciferase
expression (CALUX) bioassay; urinary excre-
tion of cadmium per millimole creatinine;
and urinary excretion of 1-hydroxypyrene per
millimole creatinine [Iex = (zblood lead + zΣ3PCBs
+ zdioxin-like activity + zurinary cadmium + zurinary
1-hydroxypyrene)/5]. We performed stepwise
regression, multiple regression, analysis of
covariance (ANCOVA), and accompanying
Fisher’s probable least-squares difference
(PLSD) post hoc tests, chi-square, non-
parametric Spearman rank correlation, Mann-
Whitney U, and Kruskal-Wallis tests using
Statview (version 5.0.1; SAS Institute, Cary,
NC, USA) or Statistica (Statsoft, Tulsa, OK,
USA) programs. We transformed parameters
that did not show a Gaussian distribution for
use as dependent variables in an ANCOVA
analysis; we used the natural logarithms of the
serum concentrations of anti-p53, TPS, AFP,
CA 15-3, CA 125, BTA, IGF-I, and sIL-2R
and the square root of the concentrations of
c-erbB-2, CEA, hPLAP, and PDGF-BB. To
select parameters associated with differences in
TAP levels for use in ANCOVA analysis or in
multiple regression, we performed a forward
stepwise regression of personal characteristics
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to locally grown food) for ANCOVA analysis
and personal, lifestyle, and internal exposure
parameters for use in multiple regression,
with each TAP as a dependent variable using
F = 4 for inclusion and F = 3.9 for exclusion.
Adjustment through ANCOVA analysis
resulted in geometric mean values. ANCOVA
analyses were limited to main effects only. In
accordance with the views formulated by
Rothman (1986), we present p-values without
adjustment for multiple testing. However, to
address concerns regarding multiple testing,
we also provide the p-values required to main-
tain an overall type I error bound of 0.05
after adjustment for multiple comparisons
according to Holm (Aickin and Gensler
1996). In relation to ANCOVA and multiple
regression analyses, we calculated p-values tak-
ing into account that 12 tests—one for each
TAP—were performed. Results from multiple
regression include the squared semipartial
correlation, which is a measure of the correla-
tion between two variables that remains after
controlling for the effects of the other predic-
tor variables and indicates the proportion of
variance accounted for by the predictor X1
relative to the total variance of Y.
Results
Internal exposure. Table 1 shows internal
exposure data (concentrations in blood,
serum, and urine). We found that residents
from Hoboken had signiﬁcantly higher blood
lead, serum zinc, and serum PCB levels than
residents from other municipalities. Also,
compared with residents from the other
municipalities, residents from Peer had
significantly higher serum cadmium levels,
higher dioxin-like activity in blood fat
(signiﬁcantly so compared with Wilrijk), and
higher 1-hydroxypyrene levels (significantly
so compared with Hoboken).
Levels of TAPs in sera from residents of dif-
ferent areas. Crude data are summarized in
Table 2. Depending on the type of TAP,
between 91.4% and 100% of participants
showed clinically normal values, except with
respect to BTA, with only 80.7% normal values.
ANCOVA revealed that place of residence was
significantly associated with differences in
c-erbB-2, BTA, and PDGF-BB levels and, after
correction for multiple comparisons, with differ-
ences in BTA and PDGF-BB levels. Using a
Fisher PLSD test, we found signiﬁcantly higher
TAP levels for both industrial suburbs but not
for the rural municipality of Peer. Women resid-
ing in Hoboken had the highest levels of
c-erbB-2, TPS, and hPLAP. For c-erbB-2, the
difference was significant for both Peer
(p = 0.0099) and Wilrijk (p = 0.026); for TPS
(p = 0.049) and hPLAP (p = 0.015), the differ-
ence was signiﬁcant only for Wilrijk. Although
residents from Hoboken had lower PDGF-BB
levels than those from Wilrijk, their levels were
signiﬁcantly higher than those of residents from
Peer (p = 0.0021). Residents of Wilrijk showed
signiﬁcantly higher levels of BTA than those of
Hoboken (p = 0.0006) and those of Peer
(p < 0.0001) and signiﬁcantly higher PDGF-BB
levels than those of Hoboken (p = 0.023) and
those of Peer (p< 0.0001).
Adjustment for potentially confounding
personal and lifestyle parameters (age; level of
education; smoking status; total number of
pregnancies; total number of months of
breast-feeding; BMI; serum levels of sele-
nium, vitamin A, vitamin E, total fat, total
cholesterol, and triglycerides; and all available
parameters related to food intake except those
related to consumption of locally grown food,
a total of 21 parameters) had no substantial
effect on the association of TAP levels with
area of residence (Table 3). Results of
ANCOVA were similar, except that area of
residence was now significantly associated
with differences in hPLAP levels but no
longer with differences in c-erbB-2 levels.
Using the Fisher PLSD test, the observed dif-
ferences between residents of the different
area’s remained signiﬁcant.
The Itap, both without correction (data
not shown) and after correction for place of
residence, all available personal and lifestyle
parameters, and all available food-intake para-
meters, was higher in residents of Hoboken
(adjusted value = 0.074) than in residents of
Wilrijk (–0.020) or Peer (–0.040), and the
difference with Peer was close to statistical
significance (p = 0.058 after correction for
confounding).
Association of TAP levels with levels of
biomarkers of internal exposure for the whole
study population. We used the levels of TAPs
as dependent variables and all 29 available
personal, lifestyle, and internal exposure para-
meters as independent variables in multiple
regression analysis (Table 4). We found a
Pollution and tumor-associated protein levels
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Table 2. Levels of TAPs: crude data.
Residence
Wilrijka,b Hobokena,b Peer Normal ANCOVA 
TAP (n = 39) (n = 61) (n = 100) valuesc p-valueb
Anti-p53 (index)  0.318 (0.050–0.589)  0.464 (0.050–1.078) 0.433 (0.073–0.755) 0.0–1.1 0.16
c-erbB-2 (pmol/mL) 2.34 (1.73–2.82)# 2.46 (1.56–3.65)*,# 2.34 (1.72–2.82) NA 0.020
TPS (U/L) 31.0 (20.4–40.8)# 34.0 (18.0–80.5)# 31.0 (21.0–55.8) 0–80 0.14
AFP (ng/mL) 1.50 (0.80–2.96)  1.55 (1.00–3.05) 1.60 (1.10–3.46) 0–20 0.37
CEA (ng/mL) 0.30 (0.30–1.58) 0.60 (0.30–2.45) 0.60 (0.30–1.60) 0–3.5 0.51
CA 15-3 (U/mL) 16.8 (11.8–25.1) 16.1 (9.4–28.2) 16.4 (10.2–25.6)  0–38 0.46
CA 125 (U/mL) 13.1 (5.7–25.5) 10.2 (5.6–25.1) 12.4 (5.9–31.0) 0–29 0.60
hPLAP (mU/L) 1.60 (0.10–28.96)# 14.75 (0.10–37.55)# 8.20 (0.10–29.95) 0–100 0.14
BTA (U/mL) 9.20 (1.72–31.52)***,## 3.50 (0.65–17.89)## 3.20 (0.65–18.50) 0–14 0.0001
IGF-I (ng/mL) 139 (88–260) 148 (91–241) 168 (102–231) 91–443 0.27
sIL-2R (U/mL) 385 (120–617) 344 (120–630) 385 (172–670) 85–961 0.26
PDGF-BB (pg/mL) 3,340 (1,792–5,532)***,# 2,550 (1,070–4,780)**,# 2,060 (280–3,534) 942–7,366 < 0.0001
NA, not available. Values shown are median (10th–90th percentile). 
aSigniﬁcant differences by Fisher’s PLSD test on crude data, between urban areas and Peer (*p < 0.01, **p < 0.0045, and
***p < 0.0001), and between Wilrijk and Hoboken (#p < 0.05, and ##p < 0.0045). bIf correction for multiple testing is imple-
mented, statistical signiﬁcance requires p ≤ 0.0045. cAs established by the manufacturer of the measuring kit and controlled
on a sample of the Flemish population.
Table 1. Internal exposure concentrations in blood, serum, and urine.
Wilrijka Hobokena Peer p-Valueb
Blood or serum concentration
Cadmium (nmol/L) 5.34 (3.56–11.21)* 5.34 (3.56–10.23)** 6.23 (3.56–11.57) 0.0097
Copper (µmol/L) 20.4 (15.1–26.6) 19.8 (16.3–25.4) 19.3 (16.5–25.8) 0.56
Lead (nmol/l) 154.4 (71.4–229.7)## 183.4 (108.6–337.8)**,## 152.0 (84.5–255.8) 0.0029
Zinc (µmol/L) 9.64 (8.17–10.89)### 10.40 (9.26–12.47)***,### 9.49 (7.65–11.41) < 0.0001
Dioxin-like activity  30.8 (5.1–71.8)** 41.9 (6.4–81.3) 44.2 (16.6–80.3) 0.010
(pg TEQ/g blood fat)
ΣPCBs
(ng/g blood fat) 379 (230–621)# 459 (270–675)***,# 370 (238–604) 0.0006
Selenium (µmol/L) 1.26 (1.04–1.53)*** 1.21 (0.96–1.52)*** 1.10 (0.88–1.31) < 0.0001
Vitamin A (µmol/L) 2.06 (1.45–2.94) 2.06 (1.62–2.95)** 1.85 (1.43–2.57) 0.036
Vitamin E (µmol/L) 30.5 (23.2–38.6) 32.6 (25.5–46.7) 32.5 (25.6–45.9) 0.093
Concentration in urine
Cadmium  0.73 (0.40–1.70) 0.74 (0.45–1.59) 0.97 (0.44–1.87) 0.43
(nmol/mmol creatinine)
1-Hydroxypyrene  46.1 (7.5–92.9) 38.0 (16.6–84.9)* 49.0 (15.1–191.3) 0.026
(pmol/mmol creatinine)
Values shown are median (10th–90th percentile). 
aSigniﬁcant differences by Mann-Whitney U test between urban areas and Peer (*p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001),
and between both urban areas (#p ≤ 0.05, ##p ≤ 0.01, and ###p ≤ 0.00). bKruskal-Wallis test for differences between areas; if
correction for multiple testing is implemented, statistical signiﬁcance requires p < 0.0063. positive correlation of blood lead with serum
levels of anti-p53, CEA, and TPS and with
Itap; a positive correlation of serum zinc with
c-erbB-2 and with TPS; a positive correlation
of dioxin-like activity in serum with CA 125;
and a negative correlation of serum copper
with IGF-I and c-erbB-2. The Iex showed a
positive association with serum levels of CEA
and of anti-p53.
If the total study population was divided
into two classes according to the Iex [women
with an Iex higher than the median versus
the others, both without correction (data not
shown)] and after correction for place of
residence, all available personal and lifestyle
parameters, and all available food-intake
parameters, the class with higher Iex levels had
significantly higher values for Itap (adjusted
mean, +0.075 vs. –0.078; p = 0.010). 
Association of TAP levels with HPRTmf.
FLEHS entailed measurements of HPRTmf in
peripheral lymphocytes for a subset of the
women who participated in the study
(van Larebeke et al. 2004). For 11 of the
12 TAPs and for Itap, we found a nonsigniﬁ-
cant positive association with HPRTmf,
whereas for PDGF-BB we found a non-
significant negative association (chi-square,
p = 0.004). In multiple regression with all
available personal, lifestyle parameters, and
internal exposure parameters, CEA showed a
signiﬁcant positive correlation with HPRTmf
(squared partial correlation = 0.108,
p = 0.018).
Discussion
Selection bias. Although possible, it is unlikely
that a selection bias occurred regarding partici-
pation in Wilrijk, Hoboken, and Peer. The
quite low response rate may be because only
one letter was sent and participants were
required to give blood and urine; only 12 of
130 respondents from Wilrijk or Hoboken
and only 14 of 125 from Peer actually refused
to participate. Concerning a series of items on
which respondents provided information
(described in “Materials and Methods”), we
found no signiﬁcant differences between par-
ticipants and persons who refused or could
not participate.
Disease and genetic constitution. The
study participants generally considered them-
selves to be in good health (data not shown).
We considered it preferable not to exclude
persons presenting with complaints or with a
disease, in order to avoid introducing a bias by
eliminating persons whose illness or com-
plaints might be inﬂuenced by environmental
factors. Because only a limited percentage of
cancer cases can be ascribed to hereditary fac-
tors (Czene et al. 2002; Verkasalo et al. 1999),
because the populations in the areas under
study are genetically probably quite similar (dis-
tances are small, the landscape permits easy
traveling, no historical divisions, all participants
spoke the same language), and because selection
bias is unlikely, we consider it improbable that
the observed differences in TAP levels as a func-
tion of area of residence or of internal exposure
are due to hereditary factors.
Differences in internal exposure. Residents
from Hoboken had signiﬁcantly higher blood
lead and serum zinc levels than residents from
other municipalities, which was to be expected
in view of the presence of a large nonferrous
smelter; they also showed signiﬁcantly higher
serum PCB levels, which was less expected.
Surprisingly, however, compared with resi-
dents from the other municipalities, residents
of the rural municipality of Peer had higher
serum cadmium levels, higher dioxin-like
activity in blood fat (significantly so com-
pared with Wilrijk), and higher 1-hydroxy-
pyrene levels (signiﬁcantly so compared with
Hoboken). We are not aware of a reliable
explanation of these high internal exposure
levels in residents of Peer; some of them may
have originated from previous exposures (cad-
mium, dioxin-like activity). Also it remains
possible that both intensive agriculture (pesti-
cides, fertilizers) and some industrial activities
at a distance of about 15 km were involved. In
2000–2001, episodes of air pollution with
polycyclic aromatic hydrocarbons and high
mutagenic activity were observed in Peer
(Du Four et al. 2004). These data and also the
van Larebeke et al.
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Table 4. Associations in multiple regression between levels of TAPs and parameters of internal exposure.
Squared
Parameter of  Regression Standardized regression  semipartial
TAP internal exposure coefﬁcient coefﬁcient (95% CI) correlation p-Valuea
Anti-p53 (index) Iex 0.35 0.23 (0.073–0.40)  0.041 0.0050
Square root of CEA  Iex 0.16 0.19 (0.033–0.35) 0.027 0.019
(ng/mL)
Anti-p53 (index)  Blood lead (nmol/L) 0.0030 0.37 (0.21–0.52) 0.10 < 0.0001
CEA (ng/mL)  Blood lead (nmol/L) 0.0021 0.18 (0.03–0.34) 0.026 0.019
TPS (U/L)  Blood lead (nmol/L) 0.107 0.22 (0.07–0.37)  0.036 0.0055
ITAP Blood lead (nmol/L) 0.001 0.29 0.063 0.00046
c-erbB-2 (pmol/mL)  Serum zinc (µmol/L) 0.072 0.19 (0.04–0.34)  0.024 0.015
TPS (U/L)  Serum zinc (µmol/L) 8.8 0.28 (0.12–0.44)  0.053 0.00078
Ln of CA 125 (U/mL)  pg TEQ/g fat 0.0042 0.19 (0.04–0.35) 0.029 0.016
Ln of CA 125 (U/mL)  Serum copper (µmol/L) 0.022 0.16 (0.007–0.32) 0.021 0.041
Square root of c-erbB-2  Serum copper (µmol/L) –0.014 –0.37 (–0.50 to –0.23)  0.11 < 0.0001
(pmol/mL)
Ln of IGF-I (ng/mL) Serum copper (µmol/L) –0.027 –0.32 (–0.47 to –0.18)  0.083 < 0.0001
CI, confidence interval. A multiple regression was performed with each TAP as the dependent variable and with all 29
available personal, lifestyle, and internal exposure parameters as independent variables. When considering association
with Iex, we performed a multiple regression with each TAP as the dependent variable and with Iex and all 21 available
personal and lifestyle parameters as independent variables. Multiple regressions using as independent variables only
age and the parameters (selected for each TAP through forward stepwise regression) showing the strongest association
with the TAP used as the dependent variable gave similar results, with the same associations showing up as statistically
signiﬁcant (data not shown).
aIf correction for multiple testing is implemented, statistical signiﬁcance requires p < 0.0063.
Table 3. Mean levels of TAPs adjusted for personal characteristics and lifestyle factors.
Residence
Wilrijka,b Hobokena,b Peer ANCOVA
TAP (n = 39) (n = 61) (n = 100) p-value b
Anti-p53 (index) 0.258  0.364 0.338 0.27
c-erbB-2 (pmol/mL) 2.36# 2.49*,# 2.28 0.098
TPS (U/L) 28.7# 38.9# 34.3 0.055
AFP (ng/mL)  1.59  1.63 1.78 0.51
CEA (ng/mL) 0.61 0.86 0.74 0.30
CA 15-3 (U/mL) 17.3 16.2 16.8 0.70
CA 125 (U/mL) 12.3 11.5 11.9 0.89
hPLAP (mU/L) 3.99# 11.12# 7.56 0.046
BTA (U/mL) 8.55**,## 3.54## 1.07 0.0008
IGF-I (ng/mL) 141 149 163 0.17
sIL-2R (U/mL) 364 331 352 0.75
PDGF-BB (pg/mL) 3,256**,# 2,587*,# 1,752 < 0.0001
Values shown are adjusted geometric means after correction through ANCOVA analysis for age; BMI; level of education;
smoking status; total number of pregnancies; total number of months of breast-feeding; serum levels of total fat, total cho-
lesterol, triglycerides, selenium, vitamin A, and vitamin E; and all available food-intake parameters except those related to
consumption of locally grown food (in total, 21 independent variables). Correction through ANCOVA analysis for only the
most relevant potential confounding factors (age, level of education, smoking status, and parameters selected for each
TAP through forward stepwise regression) gave similar results, with differences concerning c-erbB-2, hPLAP, BTA, and
PDGF-BB statistically signiﬁcant in ANCOVA (data not shown). 
aSignificant differences in a Fisher’s PLSD test after correction for the above-mentioned 21 covariates, between urban
areas and Peer (*p < 0.0045, and **p < 0.0001), and between Wilrijk and Hoboken (#p < 0.05, and ##p < 0.0045). bIf correction
for multiple testing is implemented, statistical signiﬁcance requires p ≤ 0.0045. data from an ongoing Flemish biomonitoring
program involving other rural areas (Milieu en
Gezondheid 2006) indicate that pollution is
widespread in Flanders and suggest that expo-
sure to pollutants may be quite homogeneous
in some developed Western nations.
Meaning of differences in levels of TAPs.
Whether differences in levels of TAPs, within
clinically normal ranges, are of importance in
terms of health risks is not known with cer-
tainty. There are, however, a series of observa-
tions suggesting that exposure to carcinogenic
or tumor-promoting agents leads to a slight
increase in these levels, including in those of
TAPs examined in this study (Koshida et al.
1990; Krajewska et al. 1998; Luo et al. 1999;
Lutz et al. 1997; Wong et al. 2002). Also, in a
number of studies, higher levels of TAPs, still
in the clinically normal range, were associated
with a higher risk of cancer. Such an associa-
tion was clearly demonstrated for prostate-
specific antigen and risk of prostate cancer
(Ito et al. 2003, 2005) and has also been
observed for the TAPs used in this study
(Bohlke et al. 1998; Brandt-Rauf and Pincus
1998; Giovannuci 1999; Hankinson et al.
1998; Husgafvel-Pursiainen et al. 1997; Jacobs
et al. 1996; Jeyarajah et al. 1999; Kobayashi
and Kawakubo 1994; Oka et al. 1994; Wolk
et al. 1998). The trend toward a positive asso-
ciation between levels of TAPs and HPRTmf is
consistent with the hypothesis that these para-
meters are biomarkers of exposure to carcino-
genic agents or of cancer risk.
Internal exposure and TAPs. For the
whole study population, certain parameters of
internal exposure known or suspected to be
associated with an increased risk of cancer
showed a positive association with the serum
or urinary levels of some TAPs or with the
Itap. There is ample experimental evidence
that inorganic lead is carcinogenic (Silbergeld
et al. 2000), and it is classified by the
International Agency for Research on Cancer
(IARC) as group 2B, possibly carcinogenic to
humans (IARC 1987). In the general U.S.
population, a dose–response relationship
between quartile of blood lead and all cancer
mortality showed relative risks of 1.24, 1.33,
and 1.5 for the second, third, and fourth
quartiles, respectively, compared with the ﬁrst
quartile, but this relationship was not signiﬁ-
cant (p-trend = 0.16) (Jemal et al. 2002).
Workers exposed to lead have been reported
to have an increased incidence of lung cancer
(Anttila et al. 1995). In our study on women
without occupational exposure and with
blood lead levels within “normal” limits,
blood lead showed a signiﬁcant positive corre-
lation with serum levels of anti-p53, CEA,
and TPS and with Itap, this in multiple regres-
sion analyses with all available personal and
lifestyle parameters and with all available
parameters of internal exposure. In the same
cohort, blood lead also showed a positive cor-
relation with HPRTmf (van Larebeke et al.
2004). In the vicinity of a nonferrous smelter
in Sweden, an increased incidence of lung
cancer in men has been found (Besso et al.
2003). The findings presented here and in
our previous report (van Larebeke et al.
2004), taken together, suggest that lead could
be an important carcinogen for at least part of
the population included in our study.
Dioxins are human carcinogens associated
with an increase in total cancer incidence in
humans (IARC 1997) and with endometriosis
in apes (Rier et al. 1993, 1995) and in women
(Koninckx et al. 1994; Mayani et al. 1997);
we found a positive association between
dioxin-like activity in serum and serum
CA 125. Serum CA 125 concentrations are
often higher in women with endometriosis
(Somigliana et al. 2004).
Zinc deﬁciency may enhance carcinogene-
sis, and zinc is under consideration as a chemo-
preventive agent (Riboli et al. 1996). However,
zinc also has a genotoxic potential; it has
induced cell transformation in vitro, and an
oversupply of zinc may increase the risk of
prostate cancer (European Commission 2003).
In the present study, serum zinc level showed a
positive correlation with c-erbB-2 and TPS.
The relationship between copper and the
risk of cancer is complex (Theophanides et al.
2002). In our study, serum copper showed a
weak but signiﬁcant positive correlation with
CA 125, but a quite strong negative correla-
tion with c-erbB-2 and IGF-I levels.
The Iex, integrating parameters related to
lead, cadmium, PCBs, dioxin-like activity,
and 1-hydroxypyrene, was calculated for each
participant as described in “Materials and
Methods.” Although such an index does not
take into account possible interactions, it
might give a somewhat more integrated view
on the internal exposure of an individual. The
Iex showed a positive association with Itap and
with serum levels of anti-p53 and CEA.
Area of residence and TAPs. For 5 of the
12 TAPs assessed in this study (i.e., BTA,
c-erbB-2, PDGF-BB, TPS, and hPLAP), we
observed signiﬁcant differences in serum levels
between residents of the three municipalities.
After correction for all 21 available personal or
lifestyle parameters, the differences remained
significant. For each of these five TAPs, we
observed the highest levels in one of the indus-
trial suburbs, although, compared with resi-
dents from the other municipalities, residents
of the rural municipality of Peer had higher
serum cadmium levels, higher dioxin-like activ-
ity in blood fat, and higher urinary 1-hydroxy-
pyrene levels. Even when correction through
ANCOVA analysis included all available inter-
nal exposure parameters in addition to all
21 available personal or lifestyle parameters,
these differences remained significant (data
not shown). This suggests that the higher lev-
els of some TAPs in the industrial suburbs
might, at least in part, be caused by exposures
other than those measured in this study, or by
other unknown factors somehow associated
with residence in these suburbs.
Conclusions
Although we found levels of internal exposure
to pollutants to be quite homogeneous in
Flanders, and although we observed the high-
est levels of some pollutants in the rural
municipality of Peer, we found significantly
higher levels of TAPs only in the industrial
suburbs. This suggests that, in biomonitoring,
effect biomarkers might indeed be important
in addition to biomarkers of internal exposure.
Also, this study provides some evidence indi-
cating that levels of internal exposure such as
those present in Flanders, lead in particular,
are indeed associated with biologic effects and
that even relatively small differences in these
levels are associated with observable differ-
ences in such effects. Our observations suggest
that more research into the use of TAPs to
assess, in an integrated manner, the biologic
effects of exposure to carcinogenic or tumor-
promoting agents is of interest.
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